2023
The seventh CCRC takes place for the first time in Halifax, Nova Scotia and is CCRA’s first hybrid conference. There are 872 registrants and 673 abstract submissions.
The Patient Involvement in Cancer Research Program (PIP), held in conjunction with the CCRC, engages 36 patient partners, 13 attending in-person and 23 virtually.
The CCRA research investment data is refreshed to year 2021.
Canada’s Drug Agency (CDA-AMC)
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and c... Read More »
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and c... Read More »
New Scientific Director for CIHR’s Institute of Cancer Research
Dr. Fei-Fei Liu was named Scientific Director of CIHR's Institute of Cancer Research (ICR) effective September 1, 2022. Dr. Liu has worked for more than three decades as a Clinician Scientist at the Princess Margaret Cancer Centre, where she is also the Chief of the Radiation... Read More »
Dr. Fei-Fei Liu was named Scientific Director of CIHR's Institute of Cancer Research (ICR) effective September 1, 2022. Dr. Liu has worked for more than three decades as a Clinician Scientist at the Princess Margaret Cancer Centre, where she is also the Chief of the Radiation... Read More »